Hostname: page-component-848d4c4894-v5vhk Total loading time: 0 Render date: 2024-06-21T10:44:34.762Z Has data issue: false hasContentIssue false
  • English
  • Français

Treatment with sertraline(asentra) in patients with cardio-vascular difficulties after cardio-surgical interventions

Published online by Cambridge University Press:  16 April 2020

V. Vujovic ,
S. Arsova ,
A. Novotni ,
G. Hadzi-Angelkovski ,
V. Gerazova ,
M. Stanoevska  and
L. Aleksovska
V. Vujovic
Affiliation:
Psychiatric Clinic, Skopje, Macedonia
S. Arsova
Affiliation:
Psychiatric Clinic, Skopje, Macedonia
A. Novotni
Affiliation:
Psychiatric Clinic, Skopje, Macedonia
G. Hadzi-Angelkovski
Affiliation:
Psychiatric Hospital, Skopje, Macedonia
V. Gerazova
Affiliation:
Psychiatric Clinic, Skopje, Macedonia
M. Stanoevska
Affiliation:
DOO KRKA FARMA, Skopje, Macedonia
L. Aleksovska
Affiliation:
Medical Ambulance, JPAU, Skopje, Macedonia

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.

Aim of the work: To follow the efficiency of the Sertraline (Asentra) treatment in patients with anxiety and depression symptoms after cardio-surgical interventions.

Materials and methods

During the research we included 30 patients with anxiety and depression symptoms after cardio-surgical intervention. They were chosen randomly, hospitalized and treated in the Specialized cardio-surgical clinic Filip II, Skopje. The patients were of both sexes, aged 30-65. They were all treated with Asentra tablets in dosages of 50mg taken only in the morning over the period of 3 months. They were evaluated by HAMD and HAS in the beginning, after being treated for 4 weeks and after being treated for 6 months.

Results:

In 18 patients there was a significant improvement which resulted in score decline. In 5 patients there was a slight improvement. And in 7 patients there was no significant improvement after 4 weeks or after 6 months.

Conclusion:

Asentra(Sertraline) efficient and safe SSRI anti-depressive in treating patients with anxiety and depression symptoms after cardio-surgical interventions.

Type
Poster Session 2: Depressive Disorders
Information
European Psychiatry , Volume 22 , Issue S1: 15th AEP Congress - Abstract book - 15th AEP Congress , March 2007 , pp. S247 - S248
Copyright
Copyright © European Psychiatric Association 2007
Submit a response

Comments

No Comments have been published for this article.